Dashboard
Manage Tickers

GNHAYVifor Pharma AG


$ -1.00 (-3.08 %)    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 435.98 $ 8.58 (2.01 %)
DIA $ 386.87 $ 4.54 (1.19 %)
SPY $ 511.25 $ 6.26 (1.24 %)
TLT $ 89.88 $ 0.90 (1.01 %)
GLD $ 212.97 $ -0.17 (-0.08 %)
$ 31.45
-- x --
-- x --
-- - --
$ 31.45 - $ 32.45
154
na
na
nm
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

the-daily-biotech-pulse-fda-orphan-drug-tags-for-neurocrine-editas-candidates-sale-of-bridgebios-prv-rmat-designation-for-polaritytes-product
The Daily Biotech Pulse: FDA Orphan Drug T...
05/13/2022 14:38:25

Here's a roundup of top developments in the biotech space over the last 24 hours:

csl-seals-117b-buyout-deal-of-vifor-pharma-probably-the-largest-healthcare-deal-in-2021
CSL Seals $11.7B Buyout Deal Of Vifor Phar...
12/14/2021 19:36:34

Australian biopharma CSL Ltd (OTC: CSLLY) has agreed&nb

vifor-pharma-bolsters-its-presence-in-vascular-calcification-field-via-two-acquisition-deals
Vifor Pharma Bolsters Its Presence In Vasc...
11/22/2021 11:58:04

Core News & Articles
Cara Therapeutics/Vifor Pharma's Korsuva U...
03/08/2021 13:40:10

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION